PDLI - PDL BioPharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5453.99M
Enterprise Value 3187.46M
Trailing P/E N/A
Forward P/E 125.92
PEG Ratio (5 yr expected) 1-0.44
Price/Sales (ttm)3.73
Price/Book (mrq)0.61
Enterprise Value/Revenue 31.54
Enterprise Value/EBITDA 6-88.51

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin -51.57%
Operating Margin (ttm)-21.82%

Management Effectiveness

Return on Assets (ttm)-1.50%
Return on Equity (ttm)-8.04%

Income Statement

Revenue (ttm)121.78M
Revenue Per Share (ttm)0.82
Quarterly Revenue Growth (yoy)16.90%
Gross Profit (ttm)109.45M
Net Income Avi to Common (ttm)-62.8M
Diluted EPS (ttm)-0.42
Quarterly Earnings Growth (yoy)23.30%

Balance Sheet

Total Cash (mrq)400.98M
Total Cash Per Share (mrq)2.75
Total Debt (mrq)122.78M
Total Debt/Equity (mrq)16.61
Current Ratio (mrq)10.88
Book Value Per Share (mrq)5.07

Cash Flow Statement

Operating Cash Flow (ttm)-28.8M
Levered Free Cash Flow (ttm)44.92M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.43
52-Week Change 314.91%
S&P500 52-Week Change 3-6.71%
52 Week High 33.22
52 Week Low 32.25
50-Day Moving Average 32.96
200-Day Moving Average 32.64

Share Statistics

Avg Vol (3 month) 31.66M
Avg Vol (10 day) 31.6M
Shares Outstanding 5145.98M
Float 134.07M
% Held by Insiders 11.96%
% Held by Institutions 187.67%
Shares Short (Dec 31, 2018) 415.64M
Short Ratio (Dec 31, 2018) 48.81
Short % of Float (Dec 31, 2018) 410.56%
Short % of Shares Outstanding (Dec 31, 2018) 410.72%
Shares Short (prior month Nov 30, 2018) 416.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 13, 2016
Ex-Dividend Date 4Jun 2, 2016
Last Split Factor (new per old) 21/2
Last Split Date 3Oct 10, 2001